← All peptides

PE-22-28

Spadin analog. TREK-1 channel modulator, antidepressant research.

Route
SUBQ
Typical dose range
500 mcg to 1 mg
Frequency
daily
Half-life
4 hours
Cycle on / off (days)
14 / 14
Evidence grade
C

What PE-22-28 is

PE-22-28 is spadin analog. trek-1 channel modulator, antidepressant research. It sits within neuropeptide research (attention, memory, stress resilience). Pepture keeps PE-22-28 in the library as a tracking target only, the app records what you enter but makes no recommendation about whether the compound is appropriate for you. That decision belongs with a licensed clinician.

Published pharmacokinetic data places the half-life of PE-22-28 at roughly 4 hours, and doses recorded in the community cluster around the 500 mcg to 1 mg range. Individual protocols vary widely. Jurisdictional status (FDA-approved, prescription, or research only) depends on the specific formulation and country.

How people track PE-22-28

In Pepture, PE-22-28 is typically logged alongside focus and mood ratings, sleep depth, work-session output, so cycle impact can be reviewed at the end of a block rather than by memory. The app captures dose, site, reconstitution ratio, cycle day, and any subjective rating you choose to add.

If you are considering PE-22-28 but have not started, or if you have started and want a second opinion, speak with a licensed clinician before changing any dose or cycle pattern.

Reconstitution math

Open the pre-filled PE-22-28 reconstitution calculator to compute syringe units per dose.

Reported Side Effects of PE-22-28

Effects below are summarised from peer-reviewed literature or regulatory labeling where it exists. Not medical advice. Individual responses vary.

  • Transient anxiety, restlessness, or headache PubMed
  • Dry mouth and nasal dryness with intranasal forms PubMed
  • Sleep disturbance if dosed late in the day PubMed
  • Mood changes reported in a subset of users PubMed

Compare PE-22-28

How PE-22-28 stacks up against the peers most users consider.